22 May 2013
Keywords: update, promising, new, data, neurochem, alzhemed, mild-to-moderate
Article | 26 July 2004
Neurochem has released positive interim data from an ongoing Phase IIextension study of the effects of its Alzhemed on cognitive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2004
21 May 2013
© 2013 thepharmaletter.com